Neurotensin, vectorised by Vect-Horus, is the first drug-candidate in neuroprotective hypothermia | Genetic Engineering in the Press by GEG | Scoop.it
From globenewswire.com - March 30, 2015 4:59 AM
MARSEILLE, France, March 19, 2015 (GLOBE NEWSWIRE) -- VECT-HORUS is a biotechnology company that designs and develops peptide-vectors to facilitate the delivery of drugs or imaging agents, notably in the brain. Today, VECT-HORUS announced the start of regulatory preclinical development of its candidate VH-N439, a conjugated form of neurotensin for therapeutic hypothermia.